| ［1］WHO. Global tuberculosis control 2010.Geneva:World Health Organization, 2010.［2］ UNAIDS. 2010 report on the global AIDS epidemic. Geneva: Joint United Nations Programme on HIV/AIDS, 2010.［3］ Narain JP, Raviglione MC, Kochi A. HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention［J］. Tuber Lung Dis,1992,73(6):311-321. ［4］ Ngamvithayapong J, Winkvist A, Diwan V. High AIDS awareness may cause tuberculosis patient delay: results from an HIV epidemic area, Thailand［J］. AIDS,2000,14(10):1413-1419.［5］ Rocha M, Pereira S, Ferreira L, Barros H. The role of adherence in tuberculosis HIV-positive patients treated in ambulatory regimen［J］. Eur Respir J,2003,21(5):785-788.［6］ Sabaté E.Adherence to long-term therapies: evidence for action ［M］. Geneva:World Health Organization, 2003.［7］ Vermeire E, Hearnshaw H, Van Royen P, Denekens J.Patient adherence to treatment: three decades of research. A comprehensive review［J］. J Clin Pharm Ther,2001,26(5):331-342.［8］ Gill CJ, Hamer DH, Simon JL, Thea DM, Sabin LL. No room for complacency about adherence to antiretroviral therapy in sub-SaharanAfrica［J］. AIDS,2005,19(12):1243-1249.［9］ Hirsch-Moverman Y, Daftary A, Franks J,Colson PW. Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada［J］. Int J Tuberc Lung Dis,2008,12(11):1235-1254. ［10］Osterberg L, Blaschke T. Adherence to medication［J］. N Engl J Med,2005,353(5):487-497.［11］ 常发辉. 103例肺结核病人尿液中口服抗结核药物检测［J］. 江苏预防医学,1999,10 (1)：24-25.［12］ Amuha MG, Kutyabami P, Kitutu FE, Odoi-Adome R, Kalyango JN. Non-adherence to anti-TB drugs among TB/HIV co-infected patients in Mbarara Hospital Uganda: prevalence and associated factors［J］. Afr Health Sci,2009,9Suppl 1:S8-15.［13］ 周林,陈磊,王倪,刘二勇,何金戈,刘飞鹰,王巧智,薛晓. 影响结核分枝杆菌/艾滋病病毒双重感染患者抗结核治疗转归的非治疗因素［J］. 中国防痨杂志,2010,32 (9)：539-542.［14］ 高翠南. 肺结核病人规则服药依从性的探讨［J］. 中国防痨杂志,2002,24(5)：273-274.［15］ 要玉霞,成诗明,吕青,杜昕. 贫困地区肺结核患者规则服药依从性影响因素［J］. 医药论坛杂志,2006,27(9)：37-39.［16］ Marinker M, Sharp M. From compliance to concordance: achieving shared goals in medicine taking［M］. London：Royal Pharmaceutical Society of Great Britain and Merck Sharp & Dohme,1997.［17］ Sardar P, Jha A, Roy D, Roy S, Guha P, Bandyopadhyay D. Intensive phase non-compliance to anti tubercular treatment in patients with HIV-TB coinfection: a hospital-based cross-sectional study［J］. J Community Health,2010,35(5): 471-478.［18］ 王冬梅,杨一博,黄小迅,周林,王雪静,成诗明,赖钰基,刘二勇,张拓红. TB/HIV 双重感染治疗药物不良反应监测处理和治疗依从性探讨［J］. 中国预防医学杂志,2010,1（5）：520-522.［19］ Kittikraisak W, Burapat C, Kaewsa-Ard S, Watthanaamornkiet W, Sirinak C, Sattayawuthipong W, Jittimanee S, Pobkeeree V, Varma JK. Factors associated with tuberculosis treatment default among HIV-infected tuberculosis patients in Thailand ［J］. Trans R Soc Trop Med Hyg,2009,103(1):59-66.［20］ Jittimanee SX, Nateniyom S, Kittikraisak W, Burapat C, Akksilp S, Chumpathat N, Sirinak C, Sattayawuthipong W, Varma JK. Social stigma and knowledge of tuberculosis and HIV among patients with both diseases in Thailand［J］. PLoS One,2009,4(7):e6360.［21］ Daniel OJ, Alausa OK. Treatment outcome of TB/HIV positive and TB/HIV negative patients on directly observed treatment, short course (DOTS) in Sagamu, Nigeria［J］. Niger J Med,2006,15(3):222-226.［22］ Tansuphasawadikul S, Saito W, Kim J, Phonrat B, Dhitavat J, Chamnachanan S, Pitisuttithum P. Outcomes in HIV-infected patients on antiretroviral therapy with tuberculosis［J］. Southeast Asian J Trop Med Public Health,2007,38(6):1053-1060.［23］ Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance［J］. Clin Ther,2001,23(8):1296-1310.［24］ 贺永鸿,成诗明,陈诚. 固定剂量复合剂治疗肺结核患者依从性调查与分析［J］. 中国防痨杂志,2006,28(3)：129-132.［25］ Gebremariam MK, Bjune GA, Frich JC. Barriers and facilitators of adherence to TB treatment in patients on concomitant TB and HIV treatment: a qualitative study［J］. BMC Public Health,2010,10:651.［26］ Awofeso N. Anti-tuberculosis medication side-effects constitute major factor for poor adherence to tuberculosis treatment［J］. Bull World Health Organ,2008,86(3):B-D.［27］ 朱建福,王伟炳,王法弟,沈伟,王学才,徐海涛,张国慧,徐飚. 结核病患者治疗依从性及影响因素分析［J］. 中国公共卫生,2007,23(6)：691.［28］ 周林,陈磊,赖钰基,王倪,刘二勇,何金戈,刘飞鹰,王巧智. TB/HIV双重感染患者抗结核治疗药物不良反应分析［J］. 中国防痨杂志,2011,33(2)：77-81.［29］ Rowe KA, Makhubele B, Hargreaves JR, Porter JD, Hausler HP, Pronyk PM. Adherence to TB preventive therapy for HIV-positive patients in rural South Africa: implications for antiretroviral delivery in resource-poor settings?［J］. Int J Tuberc Lung Dis,2005,9(3):263-269.［30］ 成诗明,汪宁,王雪静,万利亚,王林,周林,赖钰基,张福杰,李东民,马士文,刘刚,华建昭,刘剑君. 艾滋病合并结核病患者发现与治疗管理——卫生部TB/HIV双重感染防治试点经验［G］. 北京：2008年中国防痨协会临床委员会、基础委员会学术研讨会论文集,2008.［31］ 汤卓,黄绍标,韦彩云,杜丽群,许萱荷. 艾滋病合并结核病患者的现状调查及管理［J］. 广西医学,2009,31(2)：240-241.［32］ 黄翠英,潘彩芳,杜丽群,韦彩云,许日波. HIV/TB 双重感染病人全程督导健康教育模式［J］. 内科,2009,4(1)：3-5.［33］ Gandhi NR, Moll AP, Lalloo U, Pawinski R, Zeller K, Moodley P, Meyer E, Friedland G; Tugela Ferry Care and Research (TFCaRes) Collaboration. Successful integration of tuberculosis and HIV treatment in rural South Africa: the Sizonq’oba study［J］. J Acquir Immune Defic Syndr,2009,50(1):37-43.［34］ 林勇明,严非,陈求扬,刘晓云,吴能键. 肺结核病患者治疗依从性影响因素分析［J］.中国公共卫生,2006,22(12)：1468-1469.［35］ Lorvick J, Thompson S, Edlin BR, Kral AH, Lifson AR, Watters JK. Incentives and accessibility: a pilot study to promote adherence to TB prophylaxis in a high-risk community［J］. J Urban Health,1999,76(4):461-467.［36］Dimatteo M R. Social support and patient adherence to medical treatment: a meta-analysis［J］. Health Psychol,2004,23(2):207-218. |
京公网安备11010202007215号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.
